The row between pharma companies and the U.K. government over rebates has intensified, with the Association of the British ...

South Korea’s pharmaceutical exports rose nearly 18% quarter-on-quarter to reach $2.56 billion in the first quarter (Q1) this year, according to the Korea Health Industry Development Institute.

Epimab Biotherapeutics Inc. licensed out a development-ready KLK2/CD3 bispecific T-cell engager (TCE) for advanced prostate ...

Alzheimer’s disease (AD) is a progressive neurodegenerative disorder characterized by synaptic dysfunction, neuronal loss and the accumulation of amyloid plaques and neurofibrillary tangles, ...

Vantive Health LLC, formerly the kidney care business of Baxter International Inc., plans to invest $1 billion over the next five years in development of digitally enabled dialysis products, ...

Privately held Beckley Psytech Ltd. is to be taken over by Atai Life Sciences in an all-share deal that values the U.K.

A research team led by consultant and orthopedic surgeon Glen Liau Zi Qiang from Alexandra Hospital in Singapore developed a ...

Amber Implants BV reported no device-related adverse events were seen in any of the patients fitted with its Vcfix spinal ...

Biopharma’s nonprofit deal and grant activity continues to settle into a post-pandemic rhythm, with both showing a sustained ...

New dose-escalation data from Verastem Oncology’s phase I/II cancer study in China prompted the company to say it was ...

Recludix Pharma Inc. has nominated a lead development candidate, REX-8756, an oral, selective and reversible small-molecule ...

More phase III data coursed through the annual American Society of Clinical Oncology (ASCO) conference on Sunday, as ...